Jan 13, 2025, 08:15 AM by

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in vivo B-cell maturation antigen (BCMA) CAR-T candidate to reach the clinical stage and utilises a synthetic promoter designed using Chromatin Bio’s proprietary promoter design platform, chromatinLENS, exclusively for EsoBiotec as part of its innovative approach to immunotherapy.

Jan 10, 2025, 08:28 AM by

Biofidelity and CellCarta have announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials.

Jan 10, 2025, 08:28 AM by

Jan 10, 2025, 08:28 AM by

STEMart introduces Balloon Catheter Testing Services for the development of safe and effective medical devices.

Jan 10, 2025, 08:28 AM by

Coronado Research is pleased to announce the appointment of Jo Marshall as EVP of Data Services and Advanced Analytics.

Jan 9, 2025, 08:35 AM by

ThirdLaw Molecular Inc., a targeted drug discovery biotech reimagining molecular therapeutics, today announced the launch of its first DNA-encoded library of 4.5 billion Spiroligomer™ macromolecules. This library provides the Company and prospective partners access to a revolutionary category of molecules and the potential to transform how diseases are diagnosed and treated

Jan 9, 2025, 08:35 AM by

Bio-IT World Conference & Expo, the premier annual gathering of 3,000 innovators at the intersection of IT and life sciences, returns to Boston April 2-4, ready to meet participants’ demand for the latest information on cutting-edge technologies like generative AI, machine learning (ML), and quantum computing that promise to shape precision medicine and redefine patient outcomes.

Jan 9, 2025, 08:35 AM by

Leica Biosystems and Indica Labs today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs.

Jan 9, 2025, 01:00 AM by User Not Found

Bio-IT World | Looming uncertainties tied to the upcoming U.S. administration change will affect many key areas of artificial intelligence (AI) in 2025, according to Mark Dredze, interim deputy director for the Data Science and AI Institute at Johns Hopkins University. While a focus on deregulation appears likely, exactly how things will play out for AI governance and policy is anyone’s guess.

Jan 8, 2025, 07:53 AM by

Following an expanded collaboration between AI innovator Quris-AI and Merck KGaA and a two-year validation study to test clinical safety prediction by identifying drug candidate liver toxicity risks, it was announced this morning that Merck KGaA has adopted the startup's platform to test small molecule drug candidates prior to initiating clinical trials. Quris-AI’s platform integrates advanced AI, machine learning, generative models, patient-on-chip technology, and proprietary data to predict potential drug-induced toxicities better.

Jan 8, 2025, 07:53 AM by

ClearNote Health announced that its Avantect Multi-Cancer Detection Test was selected for the National Cancer Institute’s new Vanguard Study.

Jan 8, 2025, 01:00 AM by User Not Found

Bio-IT World | The placenta is a temporary but critical organ everyone needs to initiate their life, yet it remains one of the most understudied organs in human biology despite the possible lifelong health implications if anything it is supposed to do goes awry.

Jan 7, 2025, 01:00 AM by User Not Found

Bio-IT World | 2024 was full of innovative ideas and achievements. We spoke with industry experts and leaders about what to anticipate in the new year. Here are the full trends and predictions, including more on AI/ML, multimodal data, drug discovery, new policies, spatial biology, and more.

Jan 3, 2025, 01:00 AM by User Not Found

Bio-IT World | Last year, the world of biotech achieved much with AI, sequencing, treatment development, and more. The Trends from the Trenches podcast also covered data management strategies, embracing change, and the technologies driving data-intensive science. To kick off the new year, here are the top stories and top podcast episodes of 2024 from Bio-IT World and Trends from the Trenches.

Dec 30, 2024, 01:00 AM by User Not Found

Bio-IT World | What role will AI play in the future of drug development, especially as novel therapeutic approaches such as precision medicine drive up the complexity and cost of research? Some industry headlines hype AI as a magic bullet, capable of cutting through the headwinds of slow development cycles, shifting regulations, and high rates of failure. For companies racing to reach the market with safe and compliant new drug products, this vision of AI is compelling—and it’s driving heavy investment.

Dec 27, 2024, 01:00 AM by User Not Found

Bio-IT World | BC Platforms enters an extended joint partnership with the University of Nottingham and Nottingham University Hospitals NHS Trust to provide data sharing platforms and tools; Certis Oncology Solutions launches CertisOI Assistant, an innovative chatbot tool ; and more.

Dec 23, 2024, 08:26 AM by User Not Found

Bio-IT World | AQEMIA intends to teach its generative AI platform quantum-inspired, atomic-scale physics to transform drug discovery; DeepLife plans to develop AI-powered models of human cells, known as digital twins of cells, for drug discovery; and more.

Dec 19, 2024, 11:12 AM by

ClearNote’s Avantect Pancreatic Cancer test was selected for a large UK NHS study that will include up to 15,000 patient participants recently diagnosed with type 2 diabetes. The Avantect test is a blood-based assay designed to use key epigenomic and genomic signals to detect the earliest indicators of pancreatic cancer.

Dec 18, 2024, 08:39 AM by

Integration between eClinical’s elluminate Clinical Data Cloud and Snowflake offers modern data architecture to power clinical data science and AI, unlock data value for healthcare outcomes

Dec 18, 2024, 08:39 AM by

- Intelliguard, a leading provider of medication, inventory management and data-intelligence solutions, today announced the appointment of Giovanni Sapio as Chief Financial Officer, along with several other key executive leadership changes. These strategic moves mark a significant milestone in Intelliguard's growth journey, coinciding with the launch of its Client Excellence Organization, designed to further elevate client satisfaction and operational efficiency.